US20120006526A1 - Single-container manufacturing of biological products - Google Patents

Single-container manufacturing of biological products Download PDF

Info

Publication number
US20120006526A1
US20120006526A1 US13/236,523 US201113236523A US2012006526A1 US 20120006526 A1 US20120006526 A1 US 20120006526A1 US 201113236523 A US201113236523 A US 201113236523A US 2012006526 A1 US2012006526 A1 US 2012006526A1
Authority
US
United States
Prior art keywords
air
hvac system
zone
zones
exhaust
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/236,523
Inventor
Sarfaraz K. Niazi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapeutic Proteins Inc
Original Assignee
Therapeutic Proteins Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutic Proteins Inc filed Critical Therapeutic Proteins Inc
Priority to US13/236,523 priority Critical patent/US20120006526A1/en
Publication of US20120006526A1 publication Critical patent/US20120006526A1/en
Priority to PCT/US2012/054394 priority patent/WO2013043401A1/en
Assigned to Therapeutic Proteins International, LLC reassignment Therapeutic Proteins International, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NIAZI, SARFARAZ K.
Priority to US14/717,900 priority patent/US9593859B2/en
Assigned to NIAZI, SARFARAZ K. reassignment NIAZI, SARFARAZ K. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ADELLO BIOLOGICS, LLC
Assigned to ADELLO BIOLOGICS, LLC reassignment ADELLO BIOLOGICS, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: Therapeutic Proteins International, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24HEATING; RANGES; VENTILATING
    • F24FAIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING
    • F24F7/00Ventilation
    • F24F7/04Ventilation with ducting systems, e.g. by double walls; with natural circulation
    • F24F7/06Ventilation with ducting systems, e.g. by double walls; with natural circulation with forced air circulation, e.g. by fan positioning of a ventilator in or against a conduit
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/14Bags
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14Scaffolds; Matrices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16Vibrating; Shaking; Tilting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/06Nozzles; Sprayers; Spargers; Diffusers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/32Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of substances in solution
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10Separation or concentration of fermentation products
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q3/00Condition responsive control processes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/0318Processes

Definitions

  • HVAC heating, ventilation, and air conditioning
  • HVAC heating, ventilation, and air conditioning
  • the exhaust systems within zones remove the air to outside without recirculation.
  • Such an HVAC system will be particularly useful effective for use in biological and pharmaceutical manufacturing operations where it is critical to prevent cross contamination between zones, control the quality of air within strict ISO standards and maintain an appropriate temperature despite the heat load from the equipment operating within a zone, all at a reduced cost of installation and operation of a HVAC system. Additionally, such an HVAC system will be useful for hospitals, research laboratories and other such facilities where a structure demands varying requirements of air quality and isolation from other zones.
  • a conventional forced air variable air volume (VAV) system distributes air to terminal units installed in habitable spaces throughout a building.
  • the air is cooled or heated in central equipment zones.
  • the air supplied is called primary or ventilation air.
  • the primary air is first tempered through a large air-handling unit and then distributed to the rest of the zones through conventional air ductwork.
  • the large air-handling unit may consist of a supply fan, cooling coil, heating coil, filters, condensate drain pans, outside air dampers, sensors, controls, etc., but not any return air dampers or controls. Once the primary air leaves the air-handling unit the primary air is distributed through out the zones through air ductwork and then to in-zone terminal units such as air distribution units and terminal units.
  • a single in-zone terminal unit usually conditions a single space, but some (e.g., a large fan-coil unit) may serve several spaces.
  • Conventional forced air variable air volume systems work well in various manufacturing operations such as in pharmaceutical and biotechnology manufacturing. In most climates, these VAV systems are typically installed to condition perimeter building spaces and are designed to provide all desired space heating and cooling, outside air ventilation, and simultaneous heating and cooling in different parts of the building during intermediate seasons.
  • a conventional forced air variable air volume system generally serves also as a recirculating unit wherein the air from the various zones of a building is brought back into the unit to conserve the cost of conditioning the air; this cost can be substantial since it involves humidification or dehumidification, temperature control and air filtration. If the air is supplied to ISO controlled areas where clean air is supplied, recirculation becomes inevitable to conserve cost.
  • Air recycling has one major disadvantage: it mixes the air from various zones and is the major source of cross contamination between and among the zones.
  • a simple but extremely costly solution is to provide a separate air-handling unit for each zone in need of isolating from other zones. This is how the pharmaceutical and biotechnology industry designs its facilities.
  • the challenges become more daunting in the manufacturing of biological products where each step of manufacturing should be ideally isolated from others as the product progresses to a purer form.
  • An example of this situation arises in the purification of recombinant proteins made from mammalian cells where there remains a risk of viral contamination.
  • Each step of purification reduces the viral load and it is critical that the air from earlier steps should not mix with the air in the zones where later processes are executed.
  • the choice of separate air-handling units resolves the problem but adds substantial capital investment and a very high life-time cost of operations.
  • the large air-handling units generally recycle the circulated air and only add a small portion of fresh air. Such recycling, however, may result in air borne contaminants and bacteria being spread throughout the building resulting in “sick building syndrome.”
  • Other disadvantages may include draughts, lack of individual control, increased building height required to accommodate ducting, and noise associated with air velocity.
  • the use of in-zone terminal units may be limited to perimeter spaces, with separate systems required for other areas. More controls may be needed as compared to other systems.
  • the primary air is supplied at a constant rate with no provision for shut off, which may be a disadvantage as tenants may prefer to shut off their heating or air conditioning or management may desire to do so to reduce energy consumption.
  • low primary chilled water temperature and or deep chilled water coils are required to control space humidity accurately, which may result in more energy consumption from a chiller, cooling tower, and/or pumps.
  • a conventional forced air variable air volume system may not be appropriate for spaces with large exhaust requirements such as labs unless supplementary ventilation is provided.
  • low primary air temperatures require heavily insulated ducts.
  • the energy consumption is high because of the power needed to deliver primary air against the pressure drop of the terminal units. The initial cost for a VAV system may be high.
  • the primary air is cooled, distributed, and may be subsequently re-heated after delivery to a local zone, thus wasting energy.
  • the present invention discloses a single-pass HVAC systems to isolate zones and to maintain a required clean air quality standard is provided that operates by producing a positive pressure in all zones, while exhausting on a minimal quantity of air required by law.
  • the zones are kept clean by a recirculating fan filter in each zone.
  • the exhaust air is used to exchange heat with incoming air to conserve energy further.
  • HVAC heating, ventilation, and air conditioning
  • components and control systems.
  • an HVAC system includes distributed zone control units that locally re-circulate air to zones serviced by each respective zone control unit.
  • a zone control unit can condition the re-circulated air by adding heat, removing heat, and/or filtering.
  • an HVAC system includes an exhaust air system that extracts air from each of the HVAC zones and discharges the extracted air as exhaust air.
  • an HVAC system includes a heat recovery radiator for exchanging heat between the incoming outside intake air and the outgoing exhaust air.
  • an HVAC system includes one or more filters and/or a humidity adjustment device for conditioning the supply airflow prior to distribution to the distributed HVAC zone control units.
  • the distributed HVAC zone control units include control electronics having an Internet protocol address and can include a resident processor and memory providing local control functionality.
  • the zones are kept separate by creating a positive pressure in them by adjusting the flow of supply air and the rate of exhaust.
  • the ISO quality of air in each zone is maintained by recirculating air within the room through HEPA filters and also the temperature is individually adjusted in each zone by activating the heating and cooling systems provided in each zone.
  • HVAC systems, zone control units, and control systems provide a number of advantages. These advantages may include reduced installed system cost; improved air quality; increased Leadership in Energy and Environmental Design (LEED) points; improved quality; reduced maintenance costs; improved maintainability; reduced sound; reduced energy usage; improved control system; improved building flexibility; superior Indoor Air Quality (IAQ); exceeding American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) standards; flexible application in a variety of different types of buildings/applications; and/or reduced manufacturing costs and installed cost.
  • LED Leadership in Energy and Environmental Design
  • IAQ superior Indoor Air Quality
  • ASHRAE American Society of Heating, Refrigerating and Air-Conditioning Engineers
  • FIG. 1 describes a general layout of the HVAC system showing a common air-handling unit, exhaust and recirculation systems in the zones and a flow chart for the movement of air through a heat exchanger.
  • the HVAC systems used in various industries that require isolation of zones and providing clean air in the zones are the most expensive components of facility operations, often costing as much as 20-30% of the total cost of construction and adding a very large operation cost since most of these units are run continuously to maintain a specific ISO class of clean room.
  • Industries that would include this type of requirements are pharmaceutical manufacturing, biotechnology manufacturing, surgical rooms, health care patient facilities, electronic manufacturing operations and variety of other industries where air particulate count is strictly controlled.
  • the ISO 14664 provides a classification of clean rooms wherein not only is the particle count specified but also the size of particles; larger particles are more likely to bring biological contaminants that may be undesirable and in some instances even small particles can ruin a manufacturing process such as in electronic industry. It is for this reason that a continuously recirculating air-handling systems are used as the cost of producing such higher quality air. The use of a single-pass system would increase the cost of operations substantially.
  • the present invention provides a single-pass system but a very low capital and maintenance cost; instead of recirculating air through a common air-handling unit, each zone has its own air-recirculation unit that performs the cleaning of the air in the zone.
  • This approach also allows maintenance of a different ISO class air in each zone without affecting the quality of neighboring zones.
  • the hardware maintenance is also low since the HEPA filters provided are of smaller sizes in each zone compared to large filters needed for central recirculation systems.
  • the recirculation unit in each zone obviates the need to bring a larger volume of air as may be required to achieve a specific number of air-exchanges to clean the zone; this significant component of invention allows use of small size air-handling systems as the sole purpose of the air-handling units is to provide the replacement fresh air that is required according to local building codes such as ASHRAE 62-2004 code. In most of industrial operations this would translate into providing at least 0.12 CFM/ft 2
  • the method of isolating a plurality of zones and maintaining a pre-determined ISO quality of air and temperature according to claim 1 , wherein the fresh air supplied by the first air handling unit is 0.12 CFM/ft 2 of fresh air. So, for a 100,000 square foot clean zone facility, the air-handler will be capable of providing about 12,000 CFM. Assuming the temperature of inlet air is 90 F and the supply air is at 40 F, the energy required is about 120 Kw/hr or costing about $1.20 per hour to run a 12,000 CFM unit.
  • the zones are isolated in the present invention by maintaining a positive pressure of at least 0.05 inch water gauge in all zones; this assures that no air will enter the zones from outside and the only source of air will be the supply air; this pressure is readily maintained by adjusting the flow of supply air and the exhaust and this can be done automatically by installing pressure sensors in the zone that would govern the damper opening of the inlet and the outlet to adjust the pressure continuously.
  • the temperature in the zones is maintained by two means; first, the supply air is kept at a low temperature, generally 10 C below the lowest temperature of any zone; however, it may not be enough to maintain a required temperature as the activity in the zone would largely determine the heat output and the temperature in the zone. It is for this reason, local heating and cooling of supply air is provided through the recirculating units. This will also allow maintaining different temperatures in different zones as specific work might require. An excellent example of this will be the manufacturing of recombinant proteins where some steps require a much lower temperature such refolding or downstream purification to reduce loss of proteins.
  • the present invention will provide any temperature to any zone and compensate for any amount of heat generated within a zone without affecting other zones.
  • the air cleanliness in the zones is of great importance in many sensitive operations both biological and electronic.
  • the class of air such as class 10,000 is used in downstream purification and class 100,000 for upstream manufacturing of recombinant proteins. It is not possible using existing designs to provide two different kinds of clean air using the same air-handling unit.
  • the present invention solves this problem by disposing air-recirculating units fitted with HEPA filters within the zone. How fast these units operate will determine the number of air exchanges and that is the critical parameter for maintaining a certain class of cleanliness.
  • the exhaust air While the air exhausted is much smaller in the present invention compared to traditional systems, the exhaust air nevertheless has energy that can be of use; in hot climates, this would cool down the incoming air and in cold climates it can heat the air before it enters the air-handling unit. This is achieved by passing the exhaust air is passed through a radiator over which the fresh air passes before entering the air-handling unit; no contact between the two airflows is allowed, so the purpose of this component of invention is to conserve heat energy. This further reduces the cost of operations.
  • FIG. 1 shows a preferred embodiment of the HVAC system of the present invention.
  • the system comprises a air-handling unit 16 , which further comprises means of filtration 10 , a means of dehumidification 9 , a means of humidification 8 , a means of cooling 7 and a means of heating 6 and other associated standard features like blowers, dampers and control mechanisms.
  • the source of air for the air-handling unit 16 comes from a fresh air inlet 14 into a plenum 12 , where resides a radiator 13 and an outlet for air 17 that has undergone heat exchange with exhaust air 2 , which is then finally exhausted as outside vent 11 after exchanging heat with fresh air 14 .
  • the air intake 17 Upon reaching the air-handling unit 16 , the air intake 17 undergoes a process of conditioning before being brought as supply air 5 to vents 4 in the zones 15 .
  • the supply air vents are preferentially located in the ceiling of the zones and have a design to disperse air throughout the zone 15 .
  • a plurality of vents 4 can be disposed to in each zone.
  • Each zone 15 is further disposed with at least one exhaust system 1 that generally comprises fans, dampers and control mechanisms to remove supply air as exhaust air 2 , which then feeds the radiator 13 and then exhausted through an outside vent 11 .
  • the exhaust units are preferably located at a low level in the wall of the zones or in the floor.
  • the claimed HVAC system further comprises at least one air-recirculating unit 3 disposed in each zone and generally comprising a fan, a HEPA filter, a sealed housing and a control mechanism; the air-recirculating unit 3 is capable of circulating sufficient volume of air to comply with the requirements to clean the supply air in the zones 15 to a pre-determined ISO class. Given below are the air changes that the air-recirculating unit will be capable of meeting the ISO 14644 standards:
  • Class 1 540 to 600+ air changes per hour
  • Class 10 540 to 600 air changes per hour
  • Class 100 400 to 480 air changes per hour
  • the air-recirulation unit may be further comprise a system of ducts and supply of recirculated air.
  • the HVAC system of the present invention is single-pass HVAC system that provides only the minimal quantity of fresh air required by law.
  • the HVAC system of the present invention is used to isolate the air between various zones of a building, preventing cross-contamination.
  • the HVAC system of the present invention is used to clean air in the zones to specific ISO class for sensitive operations including manufacturing of drugs and electronic parts.
  • the HVAC system of the present invention is capable of maintaining different temperatures in each zone of a building.
  • the HVAC system of the present invention is capable of maintaining a different ISO Class of air in each zone.
  • the HVAC system of the present invention is capable of conserving energy by exchanging heat between the exhaust air and the incoming fresh air.
  • the HVAC system of the present invention is useful in the manufacturing of biological drugs wherein each step of purification requires total isolation from other zones.
  • the HVAC system of the present invention is useful in protecting patients in a hospital from infectious organisms in other patient rooms preventing hospital acquired infections, one of the largest single cost of healthcare.
  • the HVAC system of the present invention is useful in establishing safe surgical rooms.
  • the HVAC system of the present invention is inexpensive to install and run.

Abstract

A single-pass HVAC systems to isolate zones and to maintain a required clean air quality standard is provided that operates by producing a positive pressure in all zones, while exhausting on a minimal quantity of air required by law. The zones are kept clean by a recirculating fan filter in each zone. The exhaust air is used to exchange heat with incoming air to conserve energy further.

Description

    BACKGROUND
  • Various embodiments described herein relate generally to the field of heating, ventilation, and air conditioning (HVAC), and more particularly to HVAC systems able to control different zones independently that locally re-circulate air and receive supply of fresh air from a single air-handling unit. The exhaust systems within zones remove the air to outside without recirculation. Such an HVAC system will be particularly useful effective for use in biological and pharmaceutical manufacturing operations where it is critical to prevent cross contamination between zones, control the quality of air within strict ISO standards and maintain an appropriate temperature despite the heat load from the equipment operating within a zone, all at a reduced cost of installation and operation of a HVAC system. Additionally, such an HVAC system will be useful for hospitals, research laboratories and other such facilities where a structure demands varying requirements of air quality and isolation from other zones.
  • A conventional forced air variable air volume (VAV) system distributes air to terminal units installed in habitable spaces throughout a building. The air is cooled or heated in central equipment zones. The air supplied is called primary or ventilation air. The primary air is first tempered through a large air-handling unit and then distributed to the rest of the zones through conventional air ductwork. The large air-handling unit may consist of a supply fan, cooling coil, heating coil, filters, condensate drain pans, outside air dampers, sensors, controls, etc., but not any return air dampers or controls. Once the primary air leaves the air-handling unit the primary air is distributed through out the zones through air ductwork and then to in-zone terminal units such as air distribution units and terminal units. A single in-zone terminal unit usually conditions a single space, but some (e.g., a large fan-coil unit) may serve several spaces. Conventional forced air variable air volume systems work well in various manufacturing operations such as in pharmaceutical and biotechnology manufacturing. In most climates, these VAV systems are typically installed to condition perimeter building spaces and are designed to provide all desired space heating and cooling, outside air ventilation, and simultaneous heating and cooling in different parts of the building during intermediate seasons.
  • A conventional forced air variable air volume system generally serves also as a recirculating unit wherein the air from the various zones of a building is brought back into the unit to conserve the cost of conditioning the air; this cost can be substantial since it involves humidification or dehumidification, temperature control and air filtration. If the air is supplied to ISO controlled areas where clean air is supplied, recirculation becomes inevitable to conserve cost.
  • Air recycling has one major disadvantage: it mixes the air from various zones and is the major source of cross contamination between and among the zones. A simple but extremely costly solution is to provide a separate air-handling unit for each zone in need of isolating from other zones. This is how the pharmaceutical and biotechnology industry designs its facilities. The challenges become more formidable in the manufacturing of biological products where each step of manufacturing should be ideally isolated from others as the product progresses to a purer form. An example of this situation arises in the purification of recombinant proteins made from mammalian cells where there remains a risk of viral contamination. Each step of purification reduces the viral load and it is critical that the air from earlier steps should not mix with the air in the zones where later processes are executed. The choice of separate air-handling units resolves the problem but adds substantial capital investment and a very high life-time cost of operations.
  • To minimize energy consumption, the large air-handling units generally recycle the circulated air and only add a small portion of fresh air. Such recycling, however, may result in air borne contaminants and bacteria being spread throughout the building resulting in “sick building syndrome.” Other disadvantages may include draughts, lack of individual control, increased building height required to accommodate ducting, and noise associated with air velocity. Additionally, for many buildings, the use of in-zone terminal units may be limited to perimeter spaces, with separate systems required for other areas. More controls may be needed as compared to other systems. In many systems, the primary air is supplied at a constant rate with no provision for shut off, which may be a disadvantage as tenants may prefer to shut off their heating or air conditioning or management may desire to do so to reduce energy consumption. In many systems, low primary chilled water temperature and or deep chilled water coils are required to control space humidity accurately, which may result in more energy consumption from a chiller, cooling tower, and/or pumps. A conventional forced air variable air volume system may not be appropriate for spaces with large exhaust requirements such as labs unless supplementary ventilation is provided. In many systems, low primary air temperatures require heavily insulated ducts. In many systems, the energy consumption is high because of the power needed to deliver primary air against the pressure drop of the terminal units. The initial cost for a VAV system may be high. In many systems, the primary air is cooled, distributed, and may be subsequently re-heated after delivery to a local zone, thus wasting energy. In many systems, individual zone control is expensive as an individual terminal unit or fan coil unit is required for each zone, which may be costly to install and maintain, including for ancillary components such as controls. Moving large flow rates of air thru ductwork is inefficient and wastes energy. Mold and biocides may form in the ductwork and then be blown into the ambient/occupied space.
  • There remains a need to provide an HVAC system that is capable of providing a low cost solution, both in its design and operation while maintaining a complete isolation of zones and also making it possible to provide a different class of air in each zone; the ideal invention will also allow a separate temperature in each zone and requires very low maintenance.
  • The present invention discloses a single-pass HVAC systems to isolate zones and to maintain a required clean air quality standard is provided that operates by producing a positive pressure in all zones, while exhausting on a minimal quantity of air required by law. The zones are kept clean by a recirculating fan filter in each zone. The exhaust air is used to exchange heat with incoming air to conserve energy further.
  • SUMMARY
  • The following presents a simplified summary of some embodiments of the invention in order to provide a basic understanding of the invention. This summary is not an extensive overview of the invention. It is not intended to identify key/critical elements of the invention or to delineate the scope of the invention. Its sole purpose is to present some embodiments of the invention in a simplified form as a prelude to the more detailed description that is presented later.
  • The present disclosure generally provides heating, ventilation, and air conditioning (HVAC) systems, components, and control systems. In many embodiments, an HVAC system includes distributed zone control units that locally re-circulate air to zones serviced by each respective zone control unit. A zone control unit can condition the re-circulated air by adding heat, removing heat, and/or filtering.
  • In many embodiments, an HVAC system includes an exhaust air system that extracts air from each of the HVAC zones and discharges the extracted air as exhaust air. In many embodiments, an HVAC system includes a heat recovery radiator for exchanging heat between the incoming outside intake air and the outgoing exhaust air. In many embodiments, an HVAC system includes one or more filters and/or a humidity adjustment device for conditioning the supply airflow prior to distribution to the distributed HVAC zone control units. In many embodiments, the distributed HVAC zone control units include control electronics having an Internet protocol address and can include a resident processor and memory providing local control functionality. In many embodiments, the zones are kept separate by creating a positive pressure in them by adjusting the flow of supply air and the rate of exhaust. In many embodiments, the ISO quality of air in each zone is maintained by recirculating air within the room through HEPA filters and also the temperature is individually adjusted in each zone by activating the heating and cooling systems provided in each zone.
  • The disclosed HVAC systems, zone control units, and control systems provide a number of advantages. These advantages may include reduced installed system cost; improved air quality; increased Leadership in Energy and Environmental Design (LEED) points; improved quality; reduced maintenance costs; improved maintainability; reduced sound; reduced energy usage; improved control system; improved building flexibility; superior Indoor Air Quality (IAQ); exceeding American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) standards; flexible application in a variety of different types of buildings/applications; and/or reduced manufacturing costs and installed cost.
  • BRIEF DESCRIPTION OF DRAWINGS
  • FIG. 1 describes a general layout of the HVAC system showing a common air-handling unit, exhaust and recirculation systems in the zones and a flow chart for the movement of air through a heat exchanger.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The HVAC systems used in various industries that require isolation of zones and providing clean air in the zones are the most expensive components of facility operations, often costing as much as 20-30% of the total cost of construction and adding a very large operation cost since most of these units are run continuously to maintain a specific ISO class of clean room. Industries that would include this type of requirements are pharmaceutical manufacturing, biotechnology manufacturing, surgical rooms, health care patient facilities, electronic manufacturing operations and variety of other industries where air particulate count is strictly controlled. The ISO 14664 provides a classification of clean rooms wherein not only is the particle count specified but also the size of particles; larger particles are more likely to bring biological contaminants that may be undesirable and in some instances even small particles can ruin a manufacturing process such as in electronic industry. It is for this reason that a continuously recirculating air-handling systems are used as the cost of producing such higher quality air. The use of a single-pass system would increase the cost of operations substantially.
  • The present invention provides a single-pass system but a very low capital and maintenance cost; instead of recirculating air through a common air-handling unit, each zone has its own air-recirculation unit that performs the cleaning of the air in the zone. This approach also allows maintenance of a different ISO class air in each zone without affecting the quality of neighboring zones. The hardware maintenance is also low since the HEPA filters provided are of smaller sizes in each zone compared to large filters needed for central recirculation systems. The recirculation unit in each zone obviates the need to bring a larger volume of air as may be required to achieve a specific number of air-exchanges to clean the zone; this significant component of invention allows use of small size air-handling systems as the sole purpose of the air-handling units is to provide the replacement fresh air that is required according to local building codes such as ASHRAE 62-2004 code. In most of industrial operations this would translate into providing at least 0.12 CFM/ft2
  • The method of isolating a plurality of zones and maintaining a pre-determined ISO quality of air and temperature according to claim 1, wherein the fresh air supplied by the first air handling unit is 0.12 CFM/ft2 of fresh air. So, for a 100,000 square foot clean zone facility, the air-handler will be capable of providing about 12,000 CFM. Assuming the temperature of inlet air is 90 F and the supply air is at 40 F, the energy required is about 120 Kw/hr or costing about $1.20 per hour to run a 12,000 CFM unit. This should be compared with a single-pass system where the total volume of air in 100,000 sq-ft facility will be a million CFM requirement needing a 85 times larger air-handling system with more than 100 times the cost since it will require much larger ducting and other control systems. This calculation is based on about 60 exchanges per minute for clean rooms; for lesser exchanges, such as 30, the size will be proportionally smaller, yet still it will be several times the air handling unit required in the present invention. It is further noteworthy that heating or cooling at the point of use such as in each zone compared to a central heating and cooling system is more efficient as the losses of energy in the distribution of air are minimized.
  • The zones are isolated in the present invention by maintaining a positive pressure of at least 0.05 inch water gauge in all zones; this assures that no air will enter the zones from outside and the only source of air will be the supply air; this pressure is readily maintained by adjusting the flow of supply air and the exhaust and this can be done automatically by installing pressure sensors in the zone that would govern the damper opening of the inlet and the outlet to adjust the pressure continuously.
  • The temperature in the zones is maintained by two means; first, the supply air is kept at a low temperature, generally 10 C below the lowest temperature of any zone; however, it may not be enough to maintain a required temperature as the activity in the zone would largely determine the heat output and the temperature in the zone. It is for this reason, local heating and cooling of supply air is provided through the recirculating units. This will also allow maintaining different temperatures in different zones as specific work might require. An excellent example of this will be the manufacturing of recombinant proteins where some steps require a much lower temperature such refolding or downstream purification to reduce loss of proteins. The present invention will provide any temperature to any zone and compensate for any amount of heat generated within a zone without affecting other zones.
  • The air cleanliness in the zones is of great importance in many sensitive operations both biological and electronic. The class of air such as class 10,000 is used in downstream purification and class 100,000 for upstream manufacturing of recombinant proteins. It is not possible using existing designs to provide two different kinds of clean air using the same air-handling unit. The present invention solves this problem by disposing air-recirculating units fitted with HEPA filters within the zone. How fast these units operate will determine the number of air exchanges and that is the critical parameter for maintaining a certain class of cleanliness.
  • While the air exhausted is much smaller in the present invention compared to traditional systems, the exhaust air nevertheless has energy that can be of use; in hot climates, this would cool down the incoming air and in cold climates it can heat the air before it enters the air-handling unit. This is achieved by passing the exhaust air is passed through a radiator over which the fresh air passes before entering the air-handling unit; no contact between the two airflows is allowed, so the purpose of this component of invention is to conserve heat energy. This further reduces the cost of operations.
  • Now referring to the drawing, the FIG. 1 shows a preferred embodiment of the HVAC system of the present invention. The system comprises a air-handling unit 16, which further comprises means of filtration 10, a means of dehumidification 9, a means of humidification 8, a means of cooling 7 and a means of heating 6 and other associated standard features like blowers, dampers and control mechanisms. The source of air for the air-handling unit 16 comes from a fresh air inlet 14 into a plenum 12, where resides a radiator 13 and an outlet for air 17 that has undergone heat exchange with exhaust air 2, which is then finally exhausted as outside vent 11 after exchanging heat with fresh air 14. Upon reaching the air-handling unit 16, the air intake 17 undergoes a process of conditioning before being brought as supply air 5 to vents 4 in the zones 15. The supply air vents are preferentially located in the ceiling of the zones and have a design to disperse air throughout the zone 15. For larger zones, a plurality of vents 4 can be disposed to in each zone.
  • Each zone 15 is further disposed with at least one exhaust system 1 that generally comprises fans, dampers and control mechanisms to remove supply air as exhaust air 2, which then feeds the radiator 13 and then exhausted through an outside vent 11. The exhaust units are preferably located at a low level in the wall of the zones or in the floor.
  • The claimed HVAC system further comprises at least one air-recirculating unit 3 disposed in each zone and generally comprising a fan, a HEPA filter, a sealed housing and a control mechanism; the air-recirculating unit 3 is capable of circulating sufficient volume of air to comply with the requirements to clean the supply air in the zones 15 to a pre-determined ISO class. Given below are the air changes that the air-recirculating unit will be capable of meeting the ISO 14644 standards:
  • Class 1: 540 to 600+ air changes per hour
  • Class 10: 540 to 600 air changes per hour
  • Class 100: 400 to 480 air changes per hour
  • Class 1,000: 120 to 150 air changes per hour
  • Class 10,000: 45 to 60 air changes per hour
  • Class 100,000: 20 to 30 air changes per hour
  • Clean room designs also often mandate a percentage ceiling coverage of the supply of recirculated air; where such compliance is required, the air-recirulation unit may be further comprise a system of ducts and supply of recirculated air.
  • Other variations are within the spirit of the present invention. Thus, while the invention is susceptible to various modifications and alternative constructions, certain illustrated embodiments thereof are shown in the drawing and have been described above in detail. It should be understood, however, that there is no intention to limit the invention to the specific form or forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention, as defined in the appended claims.
  • In the following description, various embodiments of the present invention will be described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the embodiments. The present invention can, however, be practiced without the specific details. Furthermore, well-known features may be omitted or simplified in order not to obscure the embodiment being described.
  • In a first embodiment, the HVAC system of the present invention is single-pass HVAC system that provides only the minimal quantity of fresh air required by law.
  • In a second embodiment, the HVAC system of the present invention is used to isolate the air between various zones of a building, preventing cross-contamination.
  • In a third embodiment, the HVAC system of the present invention is used to clean air in the zones to specific ISO class for sensitive operations including manufacturing of drugs and electronic parts.
  • In a fourth embodiment, the HVAC system of the present invention is capable of maintaining different temperatures in each zone of a building.
  • In a fifth embodiment, the HVAC system of the present invention is capable of maintaining a different ISO Class of air in each zone.
  • In a sixth embodiment, the HVAC system of the present invention is capable of conserving energy by exchanging heat between the exhaust air and the incoming fresh air.
  • In a seventh embodiment, the HVAC system of the present invention is useful in the manufacturing of biological drugs wherein each step of purification requires total isolation from other zones.
  • In an eight embodiment, the HVAC system of the present invention is useful in protecting patients in a hospital from infectious organisms in other patient rooms preventing hospital acquired infections, one of the largest single cost of healthcare.
  • In a ninth embodiment, the HVAC system of the present invention is useful in establishing safe surgical rooms.
  • In a tenth embodiment, the HVAC system of the present invention is inexpensive to install and run.
  • The use of the terms “a” and “an” and “the” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. The term “connected” is to be construed as partly or wholly contained within, attached to, or joined together, even if there is something intervening. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate embodiments of the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
  • Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
  • All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.

Claims (20)

1. An HVAC system for a plurality of zones comprising:
a. At least one air-handling unit further comprising at least one air intake, at least one blower, a plurality of ducts to deliver supply air to the zones, a means of heating, a means of cooling, a means of filtering, a means of adjusting humidity and a control mechanism.
b. At least one air-exhaust unit disposed in each zone for removing the supply air from the zones further comprising at least one exhaust fan, at least one damper, an exhaust duct to carry exhaust air to an outside vent through a radiator, and a control mechanism to control the speed of exhaust flow;
c. At least one air-recirculating unit disposed in each zone further comprising at least one fan, at least one HEPA filter, a means of heating the supply air, a means of cooling the supply air, at least one return air vent, an optional damper and a control mechanism;
d. At least one heat exchanger plenum housing the radiator further comprising an inlet to draw fresh air from outside, an outlet to deliver the fresh air contacted with the radiator to the air intake of the air-handling unit, and a control mechanism.
2. The HVAC system according to claim 1, wherein a minimal volume of supply air is provided to meet a local building code for fresh air replacement.
3. The HVAC system according to claim 2, wherein the local building code is ASHRAE 62.
4. The HVAC system according to claim 2, wherein the minimum volume of supply air is 0.12 CFM/ft2.
5. The HVAC system according to claim 1, wherein the temperature of the supply air is at least 10° F. below the lowest temperature maintained in any zone.
6. The HVAC system according to claim 1, wherein the temperature of the supply air is about 40° F.
7. The HVAC system according to claim 1, wherein the supply air meets ISO 14644 Class 9 standard for air particulate counts.
8. The HVAC system according to claim 1, wherein the exhaust ducts from a plurality of zones are combined into a single exhaust duct.
9. The HVAC system according to claim 1, wherein at least one thermal sensor disposed in the zone controls the heating and cooling function of the air-recirculating unit automatically.
10. The HVAC system according to claim 1, wherein at least one air particulate counter disposed in the zone controls the speed of air-recirculation in the zone automatically.
11. The HVAC system according to claim 1, wherein at least one pressure sensor disposed in the zone controls the rate of exhaust flow to maintain a pre-determined pressure in the zone automatically.
12. The HVAC system according to claim 1, wherein the outside vent is positioned to avoid mixing the exhaust air with the fresh air intake of the heat exchanger.
13. The HVAC system according to claim 1, wherein a plurality of zones is set to different temperatures.
14. The HVAC system according to claim 1, wherein the return air vent of the air recirculating unit in the zone is disposed in the ceiling of the zone.
15. The HVAC system according to claim 14, wherein the percentage of the surface of ceiling covered by the return air vent in each zone is in accordance with ISO 14644 standard for a specific ISO class of air maintained in the zone.
16. The HVAC system according to claim 1, wherein a plurality of zones is set to different ISO classes of air.
17. A method for isolating a plurality of zones by providing the HVAC system according to claims 1-16 and controlling the exhaust flow to maintain a positive pressure in the zones.
18. The method of claim 17, wherein the pressure in a plurality of zones is at least 0.05-inch water gauge.
19. A method for maintaining a pre-determined ISO Class of clean air by providing the HVAC system according to claims 1-16 and controlling the speed of air-recirculation within the zones to provide a pre-determined number of room air exchanges per hour.
20. The method of claim 19, wherein the number of air exchanges per hour is in accordance with ISO 14644 standard.
US13/236,523 2011-04-24 2011-09-19 Single-container manufacturing of biological products Abandoned US20120006526A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/236,523 US20120006526A1 (en) 2011-04-24 2011-09-19 Single-container manufacturing of biological products
PCT/US2012/054394 WO2013043401A1 (en) 2011-04-24 2012-09-10 Clean zone hvac system
US14/717,900 US9593859B2 (en) 2011-04-24 2015-05-20 Clean zone HVAC system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/092,955 US8668886B2 (en) 2011-04-24 2011-04-24 Separative bioreactor
US13/225,407 US9500381B2 (en) 2011-04-24 2011-09-03 Multiuse reactors and related methods
US13/236,523 US20120006526A1 (en) 2011-04-24 2011-09-19 Single-container manufacturing of biological products

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/225,407 Continuation US9500381B2 (en) 2011-04-24 2011-09-03 Multiuse reactors and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/717,900 Continuation US9593859B2 (en) 2011-04-24 2015-05-20 Clean zone HVAC system

Publications (1)

Publication Number Publication Date
US20120006526A1 true US20120006526A1 (en) 2012-01-12

Family

ID=44368908

Family Applications (6)

Application Number Title Priority Date Filing Date
US13/092,955 Expired - Fee Related US8668886B2 (en) 2011-04-24 2011-04-24 Separative bioreactor
US13/225,407 Expired - Fee Related US9500381B2 (en) 2011-04-24 2011-09-03 Multiuse reactors and related methods
US13/236,523 Abandoned US20120006526A1 (en) 2011-04-24 2011-09-19 Single-container manufacturing of biological products
US13/754,167 Abandoned US20130143313A1 (en) 2011-04-24 2013-01-30 Separative harvesting device
US14/186,974 Expired - Fee Related US9200335B2 (en) 2011-04-24 2014-02-21 Separative bioreactor
US14/717,900 Expired - Fee Related US9593859B2 (en) 2011-04-24 2015-05-20 Clean zone HVAC system

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US13/092,955 Expired - Fee Related US8668886B2 (en) 2011-04-24 2011-04-24 Separative bioreactor
US13/225,407 Expired - Fee Related US9500381B2 (en) 2011-04-24 2011-09-03 Multiuse reactors and related methods

Family Applications After (3)

Application Number Title Priority Date Filing Date
US13/754,167 Abandoned US20130143313A1 (en) 2011-04-24 2013-01-30 Separative harvesting device
US14/186,974 Expired - Fee Related US9200335B2 (en) 2011-04-24 2014-02-21 Separative bioreactor
US14/717,900 Expired - Fee Related US9593859B2 (en) 2011-04-24 2015-05-20 Clean zone HVAC system

Country Status (2)

Country Link
US (6) US8668886B2 (en)
WO (1) WO2013043401A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2607883C1 (en) * 2015-08-24 2017-01-20 Акционерное общество "Центральный научно-исследовательский и проектно-экспериментальный институт промышленных зданий и сооружений - ЦНИИПромзданий" (АО "ЦНИИПромзданий") Mechanical controlled ventilation system
US20170348268A1 (en) * 2013-07-18 2017-12-07 Mochida Pharmaceutical Co., Ltd. Self-emulsifying composition of omega3 fatty acid
US20220266187A1 (en) * 2018-12-14 2022-08-25 Americair Corporation Hepa air filtration with an air handling device

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8117902B2 (en) * 2005-11-03 2012-02-21 University Of Massachusetts Nanopatterned surfaces and related methods for selective adhesion, sensing and separation
US10018613B2 (en) 2006-11-16 2018-07-10 General Electric Company Sensing system and method for analyzing a fluid at an industrial site
US10914698B2 (en) 2006-11-16 2021-02-09 General Electric Company Sensing method and system
US9658178B2 (en) 2012-09-28 2017-05-23 General Electric Company Sensor systems for measuring an interface level in a multi-phase fluid composition
US9589686B2 (en) 2006-11-16 2017-03-07 General Electric Company Apparatus for detecting contaminants in a liquid and a system for use thereof
US10260388B2 (en) 2006-11-16 2019-04-16 General Electric Company Sensing system and method
US9538657B2 (en) 2012-06-29 2017-01-03 General Electric Company Resonant sensor and an associated sensing method
US9536122B2 (en) 2014-11-04 2017-01-03 General Electric Company Disposable multivariable sensing devices having radio frequency based sensors
US8691145B2 (en) 2009-11-16 2014-04-08 Flodesign Sonics, Inc. Ultrasound and acoustophoresis for water purification
US8455242B2 (en) 2010-02-22 2013-06-04 Hyclone Laboratories, Inc. Mixing system with condenser
EP2625264B1 (en) 2010-10-08 2022-12-07 Terumo BCT, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US8542023B2 (en) 2010-11-09 2013-09-24 General Electric Company Highly selective chemical and biological sensors
WO2012075340A2 (en) 2010-12-01 2012-06-07 Alderbio Holdings Llc Anti-ngf compositions and use thereof
US11214610B2 (en) 2010-12-01 2022-01-04 H. Lundbeck A/S High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
US9067988B2 (en) 2010-12-01 2015-06-30 Alderbio Holdings Llc Methods of preventing or treating pain using anti-NGF antibodies
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US9078878B2 (en) 2010-12-01 2015-07-14 Alderbio Holdings Llc Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
US9539324B2 (en) 2010-12-01 2017-01-10 Alderbio Holdings, Llc Methods of preventing inflammation and treating pain using anti-NGF compositions
US20130260419A1 (en) * 2010-12-06 2013-10-03 Thomas C. Ransohoff Continuous processing methods for biological products
US8506797B2 (en) * 2011-04-10 2013-08-13 Therapeutic Proteins International, LLC Downstream bioprocessing device
US9469671B2 (en) * 2011-09-03 2016-10-18 Therapeutic Proteins International, LLC Closed bioreactor
US8183035B1 (en) * 2011-09-07 2012-05-22 Therapeutic Proteins International, LLC Single container manufacturing of biological product
US9284346B2 (en) * 2011-09-07 2016-03-15 Therapeutic Proteins International, LLC Preparative chromatography column and methods
US9376655B2 (en) * 2011-09-29 2016-06-28 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US8852435B2 (en) * 2011-11-29 2014-10-07 Therapeutics Proteins International, LLC Purification and separation treatment assembly (PASTA) for biological products
JP6231024B2 (en) * 2012-03-07 2017-11-15 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Disposable valves and flexible containers for pressurized bioreactors
US9783775B2 (en) 2012-03-15 2017-10-10 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US9752114B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc Bioreactor using acoustic standing waves
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9796956B2 (en) 2013-11-06 2017-10-24 Flodesign Sonics, Inc. Multi-stage acoustophoresis device
US9567559B2 (en) 2012-03-15 2017-02-14 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US10322949B2 (en) 2012-03-15 2019-06-18 Flodesign Sonics, Inc. Transducer and reflector configurations for an acoustophoretic device
US10689609B2 (en) 2012-03-15 2020-06-23 Flodesign Sonics, Inc. Acoustic bioreactor processes
US10370635B2 (en) 2012-03-15 2019-08-06 Flodesign Sonics, Inc. Acoustic separation of T cells
US9745548B2 (en) 2012-03-15 2017-08-29 Flodesign Sonics, Inc. Acoustic perfusion devices
US10953436B2 (en) 2012-03-15 2021-03-23 Flodesign Sonics, Inc. Acoustophoretic device with piezoelectric transducer array
US9752113B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc. Acoustic perfusion devices
US9272234B2 (en) 2012-03-15 2016-03-01 Flodesign Sonics, Inc. Separation of multi-component fluid through ultrasonic acoustophoresis
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
CA2868485C (en) * 2012-03-28 2020-09-15 Michael R. Ladisch Methods and systems useful for foodborne pathogen detection
KR101380406B1 (en) * 2012-04-05 2014-04-10 주식회사 포스코 Boron recovering device, method for recovering boron and boron recovering system
US10737953B2 (en) 2012-04-20 2020-08-11 Flodesign Sonics, Inc. Acoustophoretic method for use in bioreactors
US9238789B2 (en) 2012-07-21 2016-01-19 Therapeutic Proteins International, LLC Baffled single use bioreactor
US10598650B2 (en) 2012-08-22 2020-03-24 General Electric Company System and method for measuring an operative condition of a machine
DE112013004129T5 (en) 2012-08-22 2015-05-21 General Electric Company Wireless system and method for measuring an operating condition of a machine
US10684268B2 (en) 2012-09-28 2020-06-16 Bl Technologies, Inc. Sensor systems for measuring an interface level in a multi-phase fluid composition
CN104813155B (en) 2013-01-31 2019-03-01 Emd密理博公司 Disposable Direct Acquisition device
EP3020798A4 (en) * 2013-07-09 2017-02-08 Universal Bio Research Co., Ltd. Culture device, culture system, and culture method
US10160946B2 (en) 2013-09-13 2018-12-25 University Of Florida Research Foundation, Inc. Pluripotent tissue harvester and methods of manufacture thereof
US9745569B2 (en) 2013-09-13 2017-08-29 Flodesign Sonics, Inc. System for generating high concentration factors for low cell density suspensions
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
CA2935960C (en) 2014-01-08 2023-01-10 Bart Lipkens Acoustophoresis device with dual acoustophoretic chamber
WO2015120527A2 (en) * 2014-02-17 2015-08-20 Advantech Bioscience Farmacêutica Ltda Enhancement of recombinant protein expression using a membrane-based cell retention system
KR102379781B1 (en) 2014-03-21 2022-03-29 라이프 테크놀로지스 코포레이션 Condenser systems for fluid processing systems
EP3782721B1 (en) 2014-03-21 2023-08-23 Life Technologies Corporation Gas filter systems for fluid processing systems
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
MX2016012869A (en) 2014-04-01 2017-05-12 Advantech Bioscience Farmacêutica Ltda Stabilization of factor viii without calcium as an excipient.
KR20160146762A (en) 2014-04-01 2016-12-21 어드밴텍 바이오사이언스 파마큐티카 엘티디에이 Stable factor viii formulations with low sugar-glycine
US9744483B2 (en) 2014-07-02 2017-08-29 Flodesign Sonics, Inc. Large scale acoustic separation device
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
US10617070B2 (en) * 2014-10-06 2020-04-14 Life Technologies Corporation Methods and systems for culturing microbial and cellular seed cultures
RU2713126C2 (en) * 2014-10-24 2020-02-03 Джензим Корпорейшн Method for preventing contamination of system
DK3045829T3 (en) * 2015-01-19 2017-08-28 Halton Oy Control of indoor ambient condition
US10106770B2 (en) 2015-03-24 2018-10-23 Flodesign Sonics, Inc. Methods and apparatus for particle aggregation using acoustic standing waves
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US9920292B2 (en) 2015-08-31 2018-03-20 General Electric Company System and method for initiating a cell culture
US20170101435A1 (en) * 2015-10-13 2017-04-13 Therapeutic Proteins International, LLC Harvesting and perfusion apparatus
US11268056B2 (en) 2015-12-29 2022-03-08 Life Technologies Corporation Flexible bioprocessing container with partial dividing partition
WO2017123788A2 (en) * 2016-01-12 2017-07-20 Sarfaraz Niazi Multipurpose bioreactor
WO2017127666A1 (en) * 2016-01-22 2017-07-27 Saint-Gobain Performance Plastics Corporation Fluid mixing system
US10710006B2 (en) 2016-04-25 2020-07-14 Flodesign Sonics, Inc. Piezoelectric transducer for generation of an acoustic standing wave
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
EP3481361A1 (en) 2016-05-03 2019-05-15 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
DE202017002012U1 (en) * 2016-05-17 2017-08-21 Brand Gmbh + Co Kg Housing for a laboratory device
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
WO2018035182A1 (en) * 2016-08-16 2018-02-22 The Trustees Of Columbia University In The City Of New York Storage and preservation of living tissue allografts
US10933184B2 (en) * 2016-09-30 2021-03-02 Us Kidney Research Corporation Dialysate free artificial kidney device
EP3529347A1 (en) 2016-10-19 2019-08-28 Flodesign Sonics, Inc. Affinity cell extraction by acoustics
EP3532598B1 (en) * 2016-10-28 2020-09-09 Global Life Sciences Solutions USA LLC Bioreactor tray
TWI716501B (en) * 2016-11-25 2021-01-21 承源環境科技企業有限公司 Energy-saving air duct system
DK3563154T3 (en) 2016-12-28 2021-09-20 Cytiva Sweden Ab MAGNETIC IMMUNOGLOBULIN BINDING PARTICLES
TWI623707B (en) * 2017-01-06 2018-05-11 Energy-saving exhaust system
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
CN107301268A (en) * 2017-05-18 2017-10-27 哈尔滨工程大学 A kind of ship gas turbine variable stator vane angle compressor deflection angle optimization method
US10760804B2 (en) 2017-11-21 2020-09-01 Emerson Climate Technologies, Inc. Humidifier control systems and methods
EP3717624A1 (en) * 2017-11-30 2020-10-07 Corning Incorporated Package for batch chromatography
SG11202003907WA (en) 2017-12-14 2020-05-28 Flodesign Sonics Inc Acoustic transducer drive and controller
US11333589B2 (en) * 2018-03-21 2022-05-17 Smithsonian Institution Gas-liquid falling film equilibration system and methods of use
US11371726B2 (en) 2018-04-20 2022-06-28 Emerson Climate Technologies, Inc. Particulate-matter-size-based fan control system
US11226128B2 (en) 2018-04-20 2022-01-18 Emerson Climate Technologies, Inc. Indoor air quality and occupant monitoring systems and methods
WO2019204790A1 (en) 2018-04-20 2019-10-24 Emerson Climate Technologies, Inc. Systems and methods with variable mitigation thresholds
WO2019204792A1 (en) 2018-04-20 2019-10-24 Emerson Climate Technologies, Inc. Coordinated control of standalone and building indoor air quality devices and systems
US11486593B2 (en) 2018-04-20 2022-11-01 Emerson Climate Technologies, Inc. Systems and methods with variable mitigation thresholds
US11028124B2 (en) 2018-05-07 2021-06-08 Repligen Corporation Methods, devices and systems for 3-stage filtration
EP3822337B1 (en) * 2018-07-13 2022-05-04 FUJIFILM Corporation Cell culture device and cell culture method
EP3767402B1 (en) * 2019-07-19 2023-08-23 Siemens Schweiz AG System for heating, ventilation, air-conditioning
CA3158797A1 (en) * 2019-10-24 2021-04-29 Octane Biotech Inc. Cell culture chamber with improved cell-contacting surfaces
US20230008576A1 (en) * 2019-11-26 2023-01-12 Merck Sharp & Dohme Llc A host-microbe co-culture perfusion bioreactor for discovery of secreted products and novel interactions at the human-microbiota interface
US11580281B2 (en) * 2020-02-19 2023-02-14 Mitsubishi Electric Research Laboratories, Inc. System and method for designing heating, ventilating, and air-conditioning (HVAC) systems
WO2022060886A1 (en) * 2020-09-16 2022-03-24 Johnson Controls Tyco IP Holdings LLP Systems and methods to mitigate infection risk using air purification
US11299700B1 (en) 2021-02-19 2022-04-12 Acequia Biotechnology, Llc Bioreactor containers and methods of growing hairy roots using the same
CN116136943B (en) * 2023-04-20 2023-06-30 太原理工大学 Composite material pressure vessel layering sequence optimization method
CN116819103B (en) * 2023-08-28 2023-11-07 成都大熊猫繁育研究基地 Panda TSH enzyme-linked immunosorbent assay method and monoclonal antibody

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070240490A1 (en) * 2005-12-20 2007-10-18 Desrochers Eric M Duct probe assembly system for multipoint air sampling

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5582800A (en) * 1994-12-28 1996-12-10 Scientific Ecology Group Method and system for removal of harmful heteroatoms in gaseous waste streams
CN1181720A (en) * 1995-04-25 1998-05-13 伊萝莉公司 Remotely programmable matrices with memories and uses thereof
US5862982A (en) * 1997-09-24 1999-01-26 Johnson Service Company Optimal ventilation control strategy
US5997814A (en) * 1997-12-23 1999-12-07 Steris Corporation Multi-compartment plastic woven mesh dry chemistry container
CH697035A5 (en) 1999-05-04 2008-03-31 Marcel Roell Bioreactor.
US6544788B2 (en) * 2001-02-15 2003-04-08 Vijay Singh Disposable perfusion bioreactor for cell culture
US7306934B2 (en) * 2002-11-05 2007-12-11 Uchicago Argonne, Llc Porous solid ion exchange wafer for immobilizing biomolecules
US7141154B2 (en) * 2003-03-06 2006-11-28 Uchicago Argonne Llc Single-stage separation and esterification of cation salt carboxylates using electrodeionization
EP1773976B2 (en) * 2004-06-04 2020-01-01 Global Life Sciences Solutions USA LLC Disposable bioreactor systems and methods
US20060065540A1 (en) * 2004-09-24 2006-03-30 The University Of Chicago Retention of counterions in the separative bioreactor
US7682823B1 (en) * 2005-01-04 2010-03-23 Larry Runyon Bioreactor systems
US9677777B2 (en) * 2005-05-06 2017-06-13 HVAC MFG, Inc. HVAC system and zone control unit
US20100070092A1 (en) * 2008-09-16 2010-03-18 Williams Furnace Company System and method for controlling a room environment
US8550370B2 (en) * 2008-12-30 2013-10-08 Zoner Llc Automatically balancing register for HVAC systems
WO2010144747A2 (en) * 2009-06-10 2010-12-16 Cynvenio Biosystems, Inc. Flexible pouch and cartridge with fluidic circuits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070240490A1 (en) * 2005-12-20 2007-10-18 Desrochers Eric M Duct probe assembly system for multipoint air sampling

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170348268A1 (en) * 2013-07-18 2017-12-07 Mochida Pharmaceutical Co., Ltd. Self-emulsifying composition of omega3 fatty acid
RU2607883C1 (en) * 2015-08-24 2017-01-20 Акционерное общество "Центральный научно-исследовательский и проектно-экспериментальный институт промышленных зданий и сооружений - ЦНИИПромзданий" (АО "ЦНИИПромзданий") Mechanical controlled ventilation system
US20220266187A1 (en) * 2018-12-14 2022-08-25 Americair Corporation Hepa air filtration with an air handling device
US11633688B2 (en) * 2018-12-14 2023-04-25 Americair Corporation HEPA air filtration with an air handling device

Also Published As

Publication number Publication date
US9200335B2 (en) 2015-12-01
US8668886B2 (en) 2014-03-11
WO2013043401A1 (en) 2013-03-28
US20110198286A1 (en) 2011-08-18
US9500381B2 (en) 2016-11-22
US20150253022A1 (en) 2015-09-10
US20140170635A1 (en) 2014-06-19
US20130143313A1 (en) 2013-06-06
US20120231504A1 (en) 2012-09-13
US9593859B2 (en) 2017-03-14

Similar Documents

Publication Publication Date Title
US9593859B2 (en) Clean zone HVAC system
US9677777B2 (en) HVAC system and zone control unit
US5976010A (en) Energy efficient air quality maintenance system and method
US6619063B1 (en) Indoor air treatment system with HEPA filtration
US20160153671A9 (en) Hvac system and zone control unit
KR102008625B1 (en) Air conditioning system using outside air type fresh air unit for an affix ceiling
JP6253459B2 (en) Ventilator for air conditioning
CN113811720A (en) PTAC unit with dynamic intelligent air management system
JP2012202558A (en) Clean room air conditioning system
JP6836045B2 (en) Operating room air conditioning system
JP2011214799A (en) Ventilation air-conditioning system and building
JP5784654B2 (en) Air conditioning system and air conditioning method
KR100730716B1 (en) An air condition system with connect the ventilator
JPH10332181A (en) Ventilator
KR20180014122A (en) Ventilator
KR101996782B1 (en) Temperature Controlling Device For Ventilation Apparatus
JP6355660B2 (en) Air conditioning system
JP2014122740A (en) Air conditioner and air conditioning system in operation room
KR102305958B1 (en) Eco-friendly cooling and heating ventilation integrated ceiling condition unit
JPH11201511A (en) Air cleaning system
JP2001056140A (en) Clean room
JP2021177111A (en) Air conditioning system
KR100761779B1 (en) Air circulation quantity and air conditioning efficient augmentation system of down flow type thermo-hygrostat
KR102425023B1 (en) Ventilation system for data processing room
EP3926245B1 (en) Protective air supply system and method for supplying protective air flow in a clean room

Legal Events

Date Code Title Description
AS Assignment

Owner name: THERAPEUTIC PROTEINS INTERNATIONAL, LLC, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NIAZI, SARFARAZ K.;REEL/FRAME:033900/0155

Effective date: 20120824

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NIAZI, SARFARAZ K., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ADELLO BIOLOGICS, LLC;REEL/FRAME:041161/0542

Effective date: 20170201

Owner name: ADELLO BIOLOGICS, LLC, ILLINOIS

Free format text: CHANGE OF NAME;ASSIGNOR:THERAPEUTIC PROTEINS INTERNATIONAL, LLC;REEL/FRAME:041605/0782

Effective date: 20161006